News

Article

AJMC® in the Press, February 2, 2024

Author(s):

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from MedCityNews referenced an article published on AJMC.com, the website of The American Journal of Managed Care®. The article, “Innovation in Value-Based Care Requires More Data, Patient-Centered Thinking,” was a part of conference coverage for Patient-Centered Oncology Care®. The article related information on a panel discussion that focused on the Enhancing Oncology Model and the movement toward value-based care in oncology.

Related Videos
Keith Ferdinand, MD, professor of medicine and the Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine
1 expert is featured in this series.
1 expert is featured in this series.
Robin Glasco, Spencer Stuart
Edgardo S. Santos, MD, FACP, FASCO
Tiago Biachi, MD, PhD
Related Content
Image depicting the global population | Image Credit: flashmovie - stock.adobe.com
January 7th 2025

Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations

Brooke McCormick
Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
AJMC Managed Care Cast
December 31st 2024

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Christina Mattina
The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.
US Department of Veterans Affairs | image credit: jetcityimage - stock.adobe.com
January 7th 2025

CRH Programs Influence Better Health Outcomes, Access, for Veterans

Kyle Munz
Data pulled from the impact of Clinical Resource Hubs (CRHs) demonstrate the benefits these programs provide to veterans who may be experiencing gaps in care.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Studies presented at ASH 2024 added to the understanding of real-world treatment and outcomes for patients with pediatric AML. | Image credit: LASZLO - stock.adobe.com
January 7th 2025

Studies Examine Real-World Pediatric AML Treatment and Outcomes

Kimberly Rath, PharmD
Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients treated for pediatric acute myeloid leukemia (AML).
Houston, TX | Image credit: Kovacs – stock.adobe.com
January 7th 2025

Decisions and Precision in Value-Based Cancer Care

Hayden E. Klein
An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo